one-sided news — The segment only had experts paid by the drug maker and didn’t mention drug risks. Beth Mole – Jan 25, 2023 10:33 pm UTC Enlarge / A broken watch. A 13-minute segment on a recent episode of CBS’s 60 Minutes appeared to be a news story on Novo Nordisk’s weight-loss drug Wegovy
